RTX's Raytheon partners with Department of War on five landmark agreements to expand critical munition production

Core Viewpoint - Raytheon has entered into five significant framework agreements with the U.S. Department of War to enhance production capacity and expedite deliveries of various missile systems, including Tomahawk and AMRAAM, in response to growing global demand for precision munitions [1][2]. Group 1: Production Capacity and Agreements - The agreements will last up to seven years and aim to increase annual production of Tomahawk missiles to over 1,000, AMRAAM missiles to at least 1,900, and SM-6 missiles to more than 500, with many munitions expected to grow 2 to 4 times their current production rates [2]. - RTX plans to accelerate production of SM-3 IIA and SM-3 IB interceptors as part of these agreements [2][4]. Group 2: Investment and Economic Impact - The Department of War's commitment to strengthening the defense industrial base will enable RTX to invest in technology, facilities, and workforce to sustain high production rates [3]. - Investments related to these agreements have been factored into RTX's financial outlook for 2026, incorporating a collaborative funding approach to maintain free cash flow for long-term demand [5]. Group 3: Strategic Importance of Munitions - The Tomahawk cruise missile is a precision weapon capable of striking targets from 1,000 miles away and has been used operationally over 2,300 times [6]. - AMRAAM is the most widely deployed air-to-air missile, with production nearly doubling in 2025 and proven performance through over 6,000 test shots [7]. - SM-3 IB is designed for exo-atmospheric intercept of ballistic missiles and was first used in combat in April 2024 [8]. - SM-3 IIA features enhanced capabilities for faster engagement of threats and broader regional protection [9]. - SM-6 supports multiple warfare roles and has been successfully launched from various U.S. Navy platforms [10].